Clinical trial to treat rectal cancer spares major surgery
A new treatment for earlier-stage rectal cancer could transform how patients are treated for the disease, according to a landmark clinical trial.
Aug 24, 2026
0
6
Therapeutics: News and Research on Chemoradiotherapy
MeSH tree: E02.186.079
ASTRO updates guideline on radiation therapy for pancreatic cancer
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.
Aug 13, 2026
0
4
AI analysis could help tailor intensified treatment for locally advanced rectal cancer
Artificial intelligence developed by researchers at UCL has revealed a promising combination of cancer treatments that could help patients with locally advanced rectal cancer live longer.
Jul 27, 2026
0
6
Resistance training appears to restore physical strength, immune health in frail or at-risk cancer survivors
Cancer survivors significantly improved their strength and immune health after completing a 10-week resistance training program as part of a pilot study led by Shernan Holtan, MD, Chief of Blood and Marrow Transplantation ...
Jun 8, 2026
0
8
How dead tumor cells could make chemotherapy and radiotherapy work better
As tumors outgrow their blood and nutrient supplies, or respond to treatments like chemotherapy and radiotherapy, individual cancer cells die, exposing their internal scaffolds. These dead cells are an abundant source of ...
May 20, 2026
0
9
Hormone therapy remains underused in cervical cancer care as clinicians cite key barriers
Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University ...
Apr 15, 2026
0
2
Trial finds immunotherapy did not improve survival when added to chemoradiotherapy for small cell lung cancer
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, ...
Mar 12, 2026
0
10
Investigating the use of a common vitamin to treat the aggressive brain cancer glioblastoma
Edward (Ed) Waldner had no idea why he didn't feel well, but he knew he didn't feel like himself. At 55 years of age, he felt exhausted all the time. It didn't seem to matter how hard he had worked that day. He wondered if ...
Feb 10, 2026
0
55
ADRIATIC clinical trial results suggest durvalumab may offer a new path in small cell lung cancer care
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC). However, its cost raises questions about sustainability, prevention ...
Jan 12, 2026
0
17
No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial
Treating patients who have stage III non-small cell lung cancer (NSCLC) with durvalumab concurrent with chemoradiotherapy (CRT) and continuing as consolidation therapy did not improve overall survival compared to consolidation ...
Sep 8, 2025
0
11
